Latest filing published 16 Mar 2026 for ClearPoint Neuro, Inc..
This profile gathers the share dealings of Danilo D'Alessandro in ClearPoint Neuro, Inc., where the filings describe the role as finance chief. The record holds 33 filings, for trades running from 29 September 2020 to 12 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 16 March 2026 came the latest disclosure, an option exercise in ClearPoint Neuro, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations